Cardlytics Cost of Revenue vs Asset Turnover Analysis

CDLX Stock  USD 14.49  0.15  1.02%   
Cardlytics financial indicator trend analysis is way more than just evaluating Cardlytics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cardlytics is a good investment. Please check the relationship between Cardlytics Cost Of Revenue and its Asset Turnover accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.

Cost Of Revenue vs Asset Turnover

Cost of Revenue vs Asset Turnover Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cardlytics Cost of Revenue account and Asset Turnover. At this time, the significance of the direction appears to have pay attention.
The correlation between Cardlytics' Cost of Revenue and Asset Turnover is -0.73. Overlapping area represents the amount of variation of Cost of Revenue that can explain the historical movement of Asset Turnover in the same time period over historical financial statements of Cardlytics, assuming nothing else is changed. The correlation between historical values of Cardlytics' Cost of Revenue and Asset Turnover is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost of Revenue of Cardlytics are associated (or correlated) with its Asset Turnover. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Asset Turnover has no effect on the direction of Cost of Revenue i.e., Cardlytics' Cost of Revenue and Asset Turnover go up and down completely randomly.

Correlation Coefficient

-0.73
Relationship DirectionNegative 
Relationship StrengthWeak

Cost Of Revenue

Cost of Revenue is found on Cardlytics income statement and represents the costs associated with goods and services Cardlytics provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Asset Turnover

The ratio of net sales to average total assets, indicating how efficiently a company uses its assets to generate sales.
Most indicators from Cardlytics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cardlytics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.Tax Provision is likely to rise to 0.00 in 2024, whereas Selling General Administrative is likely to drop slightly above 48.4 M in 2024.
 2021 2022 2023 2024 (projected)
Depreciation And Amortization35.7M43.7M29.5M16.8M
Interest Income297K1.4M3.8M3.4M

Cardlytics fundamental ratios Correlations

0.770.970.960.950.690.320.680.910.11-0.620.160.750.97-0.33-0.190.770.750.860.84-0.540.710.320.82-0.210.87
0.770.760.730.640.20.520.50.690.46-0.810.070.640.7-0.31-0.061.00.640.850.87-0.630.930.580.82-0.210.76
0.970.760.990.90.620.330.550.920.22-0.680.230.630.98-0.36-0.320.760.630.870.84-0.50.710.330.83-0.230.86
0.960.730.990.870.640.270.520.930.21-0.640.350.60.98-0.45-0.410.710.60.820.78-0.390.660.340.79-0.290.81
0.950.640.90.870.660.430.770.84-0.08-0.540.00.80.88-0.21-0.060.640.80.850.81-0.580.60.020.79-0.150.91
0.690.20.620.640.66-0.380.420.62-0.240.050.230.390.76-0.08-0.140.190.390.280.25-0.180.120.250.240.010.34
0.320.520.330.270.43-0.380.420.270.25-0.76-0.350.490.16-0.070.150.540.490.710.71-0.550.62-0.250.72-0.090.7
0.680.50.550.520.770.420.420.43-0.39-0.28-0.230.980.51-0.250.270.490.980.590.58-0.420.47-0.040.52-0.280.69
0.910.690.920.930.840.620.270.430.27-0.650.360.50.94-0.44-0.480.690.50.820.77-0.410.630.310.8-0.350.75
0.110.460.220.21-0.08-0.240.25-0.390.27-0.690.29-0.270.2-0.18-0.440.47-0.270.280.3-0.170.610.560.47-0.030.1
-0.62-0.81-0.68-0.64-0.540.05-0.76-0.28-0.65-0.69-0.04-0.41-0.580.280.24-0.83-0.41-0.85-0.870.57-0.91-0.33-0.940.16-0.75
0.160.070.230.350.00.23-0.35-0.230.360.29-0.04-0.240.31-0.75-0.860.0-0.24-0.08-0.10.63-0.030.340.03-0.48-0.19
0.750.640.630.60.80.390.490.980.5-0.27-0.41-0.240.57-0.240.270.641.00.70.71-0.530.60.080.62-0.250.78
0.970.70.980.980.880.760.160.510.940.2-0.580.310.57-0.35-0.350.690.570.780.75-0.440.640.390.76-0.190.77
-0.33-0.31-0.36-0.45-0.21-0.08-0.07-0.25-0.44-0.180.28-0.75-0.24-0.350.76-0.24-0.24-0.21-0.18-0.44-0.26-0.29-0.30.89-0.13
-0.19-0.06-0.32-0.41-0.06-0.140.150.27-0.48-0.440.24-0.860.27-0.350.76-0.010.27-0.07-0.02-0.48-0.07-0.23-0.210.620.04
0.771.00.760.710.640.190.540.490.690.47-0.830.00.640.69-0.24-0.010.640.870.89-0.690.930.550.83-0.160.78
0.750.640.630.60.80.390.490.980.5-0.27-0.41-0.241.00.57-0.240.270.640.70.71-0.530.60.080.62-0.250.78
0.860.850.870.820.850.280.710.590.820.28-0.85-0.080.70.78-0.21-0.070.870.70.99-0.730.830.190.94-0.150.97
0.840.870.840.780.810.250.710.580.770.3-0.87-0.10.710.75-0.18-0.020.890.710.99-0.730.850.240.93-0.10.94
-0.54-0.63-0.5-0.39-0.58-0.18-0.55-0.42-0.41-0.170.570.63-0.53-0.44-0.44-0.48-0.69-0.53-0.73-0.73-0.65-0.1-0.63-0.32-0.74
0.710.930.710.660.60.120.620.470.630.61-0.91-0.030.60.64-0.26-0.070.930.60.830.85-0.650.530.9-0.160.74
0.320.580.330.340.020.25-0.25-0.040.310.56-0.330.340.080.39-0.29-0.230.550.080.190.24-0.10.530.23-0.150.03
0.820.820.830.790.790.240.720.520.80.47-0.940.030.620.76-0.3-0.210.830.620.940.93-0.630.90.23-0.180.89
-0.21-0.21-0.23-0.29-0.150.01-0.09-0.28-0.35-0.030.16-0.48-0.25-0.190.890.62-0.16-0.25-0.15-0.1-0.32-0.16-0.15-0.18-0.1
0.870.760.860.810.910.340.70.690.750.1-0.75-0.190.780.77-0.130.040.780.780.970.94-0.740.740.030.89-0.1
Click cells to compare fundamentals

Cardlytics Account Relationship Matchups

Cardlytics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets224.3M422.5M1.3B691.2M574.1M440.0M
Short Long Term Debt Total37K188.1M197.2M235.3M266.1M138.7M
Other Current Liab76.0M74.8M313.4M238.5M162.2M126.0M
Total Current Liabilities78.4M81.3M327.4M248.9M171.1M135.4M
Total Stockholder Equity143.3M157.2M690.7M211.6M134.8M98.0M
Other Liab2.6M679K54.5M334K384.1K364.9K
Net Tangible Assets139.1M150.4M(190.5M)158.1M181.8M190.9M
Property Plant And Equipment Net14.3M24.6M21.5M12.5M10.6M14.5M
Current Deferred Revenue1.1M349K3.3M1.8M2.4M1.3M
Net Debt(104.4M)(105.1M)(36.2M)113.4M174.3M183.0M
Retained Earnings(338.6M)(394.1M)(522.6M)(976.6M)(1.1B)(1.1B)
Accounts Payable1.2M1.4M4.6M3.8M4.4M3.2M
Cash104.5M293.2M233.5M121.9M91.8M116.8M
Non Current Assets Total28.6M36.9M905.1M441.2M350.2M226.1M
Non Currrent Assets Other10.1M5.6M2.4M2.6M2.7M2.6M
Other Assets10.1M22.6M2.4M2.6M2.3M2.2M
Long Term Debt13K174.0M184.4M226.0M257.6M130.8M
Cash And Short Term Investments104.5M293.2M233.5M121.9M91.8M116.8M
Net Receivables85.4M86.6M117.2M120.1M126.0M89.2M
Common Stock Shares Outstanding23.7M27.2M32.2M33.4M36.5M26.9M
Long Term Debt Total13K174.0M184.4M226.0M260.0M273.0M
Liabilities And Stockholders Equity224.3M422.5M1.3B691.2M574.1M440.0M
Non Current Liabilities Total2.6M184.1M245.7M230.7M268.2M206.5M
Capital Surpluse480.6M551.4M1.2B1.2B1.4B1.4B
Inventory129K110K95K80K72K68.4K
Other Current Assets5.8M5.7M8.0M8.0M6.1M5.2M
Other Stockholder Equity480.6M551.4M1.2B1.2B1.2B628.4M
Total Liab81.0M265.3M573.1M479.6M439.3M342.0M
Deferred Long Term Liab8.5M3.8M139K198K178.2K169.3K
Property Plant And Equipment Gross14.3M24.6M11.3M5.9M43.7M45.9M
Total Current Assets195.7M385.6M358.7M250.0M223.9M213.8M
Accumulated Other Comprehensive Income1.3M(192K)486K5.6M2.5M1.9M
Short Term Debt24K4.7M6.0M4.9M2.1M3.6M
Intangible Assets4.2M6.7M138.7M73.4M59.6M35.1M
Property Plant Equipment14.3M13.9M21.5M5.9M6.8M12.5M

Pair Trading with Cardlytics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cardlytics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardlytics will appreciate offsetting losses from the drop in the long position's value.

Moving against Cardlytics Stock

  0.74WMG Warner Music Group Financial Report 14th of May 2024 PairCorr
  0.69EVC Entravision Communications Financial Report 2nd of May 2024 PairCorr
  0.66IAS Integral Ad Science Buyout TrendPairCorr
  0.54ABTS Abits Group Symbol ChangePairCorr
  0.43RSVRW Reservoir Media ManaPairCorr
The ability to find closely correlated positions to Cardlytics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cardlytics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cardlytics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cardlytics to buy it.
The correlation of Cardlytics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cardlytics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cardlytics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cardlytics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Cardlytics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cardlytics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cardlytics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cardlytics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for Cardlytics Stock analysis

When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Cardlytics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardlytics. If investors know Cardlytics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardlytics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.57)
Earnings Share
(3.69)
Revenue Per Share
8.474
Quarterly Revenue Growth
0.081
Return On Assets
(0.06)
The market value of Cardlytics is measured differently than its book value, which is the value of Cardlytics that is recorded on the company's balance sheet. Investors also form their own opinion of Cardlytics' value that differs from its market value or its book value, called intrinsic value, which is Cardlytics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardlytics' market value can be influenced by many factors that don't directly affect Cardlytics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardlytics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardlytics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardlytics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.